Washington, DC, United States of America

Alberto Murat Croci

This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignees: Ibex Biosciences, Inc., Virtual Draft, LLC, Other. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alberto Murat Croci. Retrieved from https://idiyas.com/inventor/alberto-murat-croci

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Alberto Murat Croci - Pioneering Inventor from Washington, DC

Introduction: Alberto Murat Croci is a renowned inventor based in Washington, DC, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Alberto Murat Croci holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Alberto Murat Croci has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized their respective industries.

Collaborations: Throughout his career, Alberto Murat Croci has collaborated with top scientists, engineers, and inventors from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Alberto Murat Croci's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…